{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:13Z","timestamp":1791300493382,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vph.2005.09.003","type":"journal-article","created":{"date-parts":[[2005,11,8]],"date-time":"2005-11-08T12:14:46Z","timestamp":1131452086000},"page":"1-9","source":"Crossref","is-referenced-by-count":117,"title":["Plasminogen activators: A comparison"],"prefix":"10.1016","volume":"44","author":[{"given":"Dev B.","family":"Baruah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra N.","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2005.09.003_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biotechadv.2003.09.004","article-title":"Streptokinase \u2014 a clinically useful thrombolytic agent research review paper","volume":"22","author":"Banerjee","year":"2004","journal-title":"Biotechnol. Adv."},{"issue":"7","key":"10.1016\/j.vph.2005.09.003_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archsurg.1986.01400070035007","article-title":"Intra arterial fibrinolytic therapy, efficacy of streptokinase vs urokinase","volume":"121","author":"Belkin","year":"1986","journal-title":"Arch. Surg."},{"key":"10.1016\/j.vph.2005.09.003_bib43","unstructured":"Caridi, J.G., et al., 2005. Thrombolysis. www.venousaccess.com\/thrombolysis.htm, Dated 12.03.2005."},{"key":"10.1016\/j.vph.2005.09.003_bib3","first-page":"244","volume":"vol. 45","author":"Castellino","year":"1977"},{"key":"10.1016\/j.vph.2005.09.003_bib4","series-title":"Current Index of Medical Specialities-88, India, January 2005","first-page":"156","year":"2005"},{"key":"10.1016\/j.vph.2005.09.003_bib5","series-title":"Hemostasis and Thrombosis, Basic Principle and Clinical Practices","year":"1994"},{"key":"10.1016\/j.vph.2005.09.003_bib29","unstructured":"Cramer, P., Martinet, J., 2005. Thrombolytic agents. www.Bioimpact.org Sep. 2004. www.france-biotech.org\/Load.asp? ID DOC=1297."},{"key":"10.1016\/j.vph.2005.09.003_bib6","unstructured":"Dectcher, Steven R., Jaff, Michal R. Pharmacologic and clinical characteristics of thrombolytic agents. [Rev Cardiovasc Med. 2002; 3 (suppl 2): S25\u2013S33] (www.medreviews.com\/pdf\/articles\/RICM3Suppl2S25pdf)."},{"key":"10.1016\/j.vph.2005.09.003_bib32","unstructured":"Feied, C., Handler, J.A., 2004. Thrombolytic therapy. www.emedicine.com\/emerg\/topic831.htm, Dated 12.03.2005."},{"key":"10.1016\/j.vph.2005.09.003_bib7","unstructured":"Goodman, Louis S., Gillman, Alfred, 1995. The Pharmacological Basis of Therapeutics, 5th edition. Page 956,1364,1365. Macmillan publishing Co. Inc. New York."},{"key":"10.1016\/j.vph.2005.09.003_bib12","article-title":"Lanoteplase beats alteplase in AMI","author":"Heijer","year":"1998","journal-title":"J. Watch Cardiol."},{"key":"10.1016\/j.vph.2005.09.003_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000006918","article-title":"Thrombolytic therapy with streptokinase and tissue plasminogen activation in a patient with suspected AMI. A decision analysis","volume":"91","author":"Hiatt","year":"1999","journal-title":"Cardiology"},{"key":"10.1016\/j.vph.2005.09.003_bib9","unstructured":"http:\/\/www.cardiologyrounds.ca\/crus\/crcane-06-98.pdf. \u201cNew directions in thrombolytic therapy\u201d Wayne hoping Kong, Shaun Goodman."},{"key":"10.1016\/j.vph.2005.09.003_bib10","unstructured":"http:\/\/www.medscape.com\/viewarticle. \u201cPharmacology of New Plasminogen Activators\u201d."},{"issue":"2","key":"10.1016\/j.vph.2005.09.003_bib11","first-page":"151","article-title":"The role of thrombolytic drugs in the management of AMI and Stroke","volume":"19","author":"Iqbal","year":"2002","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.vph.2005.09.003_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2165\/00002018-199513020-00002","article-title":"How safe is re administration of steptokinase","volume":"2","author":"Lee","year":"1995","journal-title":"Drug Safety"},{"key":"10.1016\/j.vph.2005.09.003_bib14","unstructured":"Lievadot, Joan P., Giugliano, Robert P. \u201cNew thrombolytic agents: does direct angioplasty still have a role?\u201d current interventional cardiology reports 2000, 2: 250\u2013257. www.biomedcentral.com."},{"key":"10.1016\/j.vph.2005.09.003_bib15","unstructured":"National academy of science of the United States, Jan 19, 1999, V96 i2 p 686."},{"issue":"2","key":"10.1016\/j.vph.2005.09.003_bib17","first-page":"212","article-title":"New thromobolytic agent","volume":"45","author":"Nguyen","year":"1987","journal-title":"Ann. Biol. Clin. (Paris)"},{"key":"10.1016\/j.vph.2005.09.003_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0037-1615568","article-title":"Pharmacokinetics and pharmacodynamics of lanoteplase","volume":"82","author":"Nordt","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2005.09.003_bib22","unstructured":"Ouriel, K., 2002. Safety and efficacy of various thrombolytic agent, vol. 3 suppl. 2, reviews in cardiovascular medicine s17, http:\/\/www.medreviews.com\/pdfs\/articles\/RICM_3suppl2_s17.pdf, Dated 15.03.2005."},{"issue":"5","key":"10.1016\/j.vph.2005.09.003_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0741-5214(95)70045-5","article-title":"Comparison of streptokinase, urokinase and recombinant tissue plasminogen activator in an in vitro model of venous thrombosis","volume":"22","author":"Ouriel","year":"1995","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.vph.2005.09.003_bib20","doi-asserted-by":"crossref","unstructured":"Ouriel, Kenneth, Gray, Bruce, Clair, Daniel G., Olin, Jeffrey, 2000. \u201cComplication associated with the use of urokinase and recombinant. Tissue plasminogen activator for catheter directed peripheral arterial and venous thrombolysis\u201d, www.medreviews.com.","DOI":"10.1016\/S1051-0443(07)61420-1"},{"key":"10.1016\/j.vph.2005.09.003_bib41","unstructured":"Productmonograph PRCathflo\u00ae (alteplase, recombinant), www.rochecanada.com\/pdf\/Cathflo%20PM%20E.pdf., Dated 22.03.2005."},{"key":"10.1016\/j.vph.2005.09.003_bib40","unstructured":"RecombinantHumanTissuePlasminogenActivator-TPA, www.prospec.co.il\/~prospec\/cart\/catalog\/rHuTPA.html, ProSpec-Tany TechnoGene Ltd, Dated 11.03.2005."},{"key":"10.1016\/j.vph.2005.09.003_bib21","series-title":"Hand Book of Pharmaceutical Biotechnology, Chapter-4","first-page":"65","author":"Rho","year":"2004"},{"key":"10.1016\/j.vph.2005.09.003_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.4960220303","article-title":"New plasminogen activators\u2014a clinical review","volume":"22","author":"Ross","year":"1999","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.vph.2005.09.003_bib23","unstructured":"Satoshkar, R.S., Bhandarkar, S.D., Ainapure, S.S., 1998 \u201cPharmacology and Therapeutics\u201d. Revised 16th edition. Pages 460, 461, 1030, 1031. Popular prakashan, Mumbai, India."},{"key":"10.1016\/j.vph.2005.09.003_bib24","unstructured":"STN easy online database. Topic \u2014 \u201cplasminogen and plasminogen activator\u201d www.stneasy.cas.org."},{"key":"10.1016\/j.vph.2005.09.003_bib42","unstructured":"Tenecteplase\u2014clinical pharmacology, www.rxlist.com\/generic2\/tenecteplase_cp-htm, Dated 20.04.2005."},{"key":"10.1016\/j.vph.2005.09.003_bib25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","article-title":"A comparison of Reteplase with Alteplase for AMI","volume":"337","author":"Topal","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vph.2005.09.003_bib26","series-title":"Essentials of Medical Pharmacology","first-page":"609","author":"Tripathi","year":"2003"},{"issue":"1","key":"10.1016\/j.vph.2005.09.003_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1148\/radiology.165.1.3628756","article-title":"Urokinase VS streptokinase in local thrombolysis","volume":"165","author":"Van Breda","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.vph.2005.09.003_bib33","first-page":"2044","article-title":"Recombinant staphylokinase","volume":"92","author":"Vander Schueren","year":"1995","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.vph.2005.09.003_bib28","first-page":"20449","article-title":"A randomized trial of r-staphylokinase vs alteplase for coronary artery patency in AMI, the STAR trial group","volume":"92","author":"Vander Schueren","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2005.09.003_bib30","unstructured":"www.biology.iupui.edu\/biocourses\/N100\/2KS."},{"key":"10.1016\/j.vph.2005.09.003_bib31","unstructured":"www.Biopharma.com. (Biopharmaceutical product in the US market)."},{"key":"10.1016\/j.vph.2005.09.003_bib35","unstructured":"www.gene.com."},{"key":"10.1016\/j.vph.2005.09.003_bib36","unstructured":"www.gpnotebook.co.uk (Tissue plasminogen activator)."},{"key":"10.1016\/j.vph.2005.09.003_bib37","unstructured":"www.Healthtouch.com (Alteplase, recombinant (Injection))."},{"key":"10.1016\/j.vph.2005.09.003_bib38","unstructured":"www.madsci.com\/Manu\/ches_thr.htm (Thrombolytics)."},{"key":"10.1016\/j.vph.2005.09.003_bib39","unstructured":"www.pharmacy.pitt.edu\/pdf\/cathflomonographfinalpdf (Cathflo Activase\u00ae(t-PA, alteplase))."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189105001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189105001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T18:37:15Z","timestamp":1586543835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189105001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1537189105001916"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2005.09.003","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}